BIOVERATIV ORD SHS/ US09075E1001 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2022-02-22
Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., as Chief Technical Operations Officer
GlobeNewswire
2022-02-04
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
GlobeNewswire
2022-01-05
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of R...
GlobeNewswire
2021-10-28
Sanofi : Strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER(1)
GlobeNewswire
2021-04-28
Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER
GlobeNewswire
2021-03-16
GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Progr...
GlobeNewswire
2021-02-05
Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER
GlobeNewswire
2020-05-06
Oxford Biomedica plc Preliminary results for the year ended 31 December 2019
GlobeNewswire
2019-08-27
Amunix Pharmaceuticals Announces the Appointment of Dr. Maninder Hora as Chief Technical Operations ...
GlobeNewswire
2019-08-02
The Global Gene Therapy Market, 2019 to 2024: Product Pipeline, Market Size, and Forecasts
GlobeNewswire
2019-07-31
Apellis Pharmaceuticals Reports Second Quarter 2019 Business Update and Financial Results